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CONCLUSION
These data suggest that low levels of AMU in the veal industry do not need to be associated with problems of increased mortality, and that a further reduction 
in AMU should be attempted. The mortality risk of this population is the lowest reported for the veal calf industry system worldwide. Identification of herd size, 
use of cephalosporins and long-acting macrolides as risk/protective factors for mortality can aid the sector towards a further reduction in mortality. 
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Figure 2. Association between antimicrobial use (DDDvet/year) and mortality (%) in white dairy veal calves (76
production cycles, 29 veal farms, 2014-2016, Belgium). Orange triangles: veal company 1 (coefficient (R2) = 0.176;
P = < 0.05), purple circles: veal company 2 (R2 = 0.008, P = 0.57).
*
**
**
**
* *
*
0
5
10
15
20
25
30
35
40
45
50
AMX MLA DOX CM COL OTC AS FQ FF SXT LS CS3/4 PEN
AM
U
 (D
DD
ve
t/
ye
ar
)
Integration 1 Integration 2
Figure 3. Consumption of different antimicrobial classes (DDDvet/year) stratified by veal company (76 production
cycles, 29 farms, 2014-2016, Belgium). AMX: amoxicillin, MLA: long-acting macrolides, DOX: doxycycline, CM: classic
macrolides, COL: colistin, OTC: oxytetracycline, AS: aminosides, FQ: fluoroquinolones, FF: florphenicol, SXT: trimethoprim
sulfonamides, LS: lincosamides, CS3/4: cephalosporines of 3rd and 4th generation, PEN: penicillin. Antimicrobial use is
expressed as DDDvet/year based on live weight. * P < 0.05; ** P < 0.001.
The veal calf industry is widely known for their high level of antimicrobial use (AMU) caused by
their sector structure, which contains major risk factors for disease (i.g. purchase, transport,
commingling). AMU in Belgian veal calves already reduced drastically between 2007 and 2016
(∼46%), but further reduction remains necessary. However, farmers and veterinarians are
concerned, that decrease in AMU would increase mortality, and therefore hamper animal welfare.
To give notice to this concern, the objective of this study was to explore the relationship between
AMU (total and different classes) and mortality. The hypothesis was that a lower AMU would be
associated with an increased mortality.
• Retrospective cohort study 
• AMU and mortality data over 2014-2016 
• Data from largest veal practice in Belgium  
• 76 production cycles
• 29 farms
• 45.001 dairy veal calves
• 2 veal companies 
Figure 4. Association between herd size and mortality (%)(R2 = 0.23. P < 0.001) in dairy white veal calves (76
production cycles, 29 farms, 2014-2016, Belgium).
Mean Range Veal company 1 Veal company 2
AMU (DDDvet/year) 30.1 10.7-55.7 22.4 (± 5.7) 35.9 (± 9.3)
Mortality (%) 3.1 0.0-7.1 4.1 (± 1.4) 2.3 (± 1.4)
Herd size (number of calves) 592 228-1171 731 (± 202) 485 (± 153)
• Huge range in AMU and mortality risk over different farms (Table 1)
• No association between overall AMU and mortality risk (Figure 1)
• Association between AMU and mortality veal companies (Figure 2)
 Veal company 1: positive association
 Veal company 2: no association 
• Difference in use of antimicrobial classes between veal companies (Figure 3)
• Risk factors for mortality: herd size (Figure 4), use of cephalosporines 3rd/4th generation
• Protective factor for mortality: use of long-acting macrolides
Table 1. Descriptives of mean antimicrobial use (AMU), mortality risk (%) and herd size (76 production cycles, 29 veal farms, 2014-2016, Belgium)
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Figure 1. No association between antimicrobial use (DDDvet/year) and mortality (%) in white dairy veal calves
(coefficient (R2) = 0.118; P = 0.34), hereby rejecting the working hypothesis (76 production cycles, 29 veal farms, 2014-
2016, Belgium).
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